[Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid].
Identifieur interne : 00B717 ( Main/Exploration ); précédent : 00B716; suivant : 00B718[Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid].
Auteurs : V. Waldmann ; W. Kempf ; G. Burg ; R. DummerSource :
- Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete [ 0017-8470 ] ; 1997.
Descripteurs français
- KwdFr :
- Ciclosporine (effets indésirables), Ciclosporine (usage thérapeutique), Facteurs de risque, Humains, Immunosuppresseurs (effets indésirables), Immunosuppresseurs (usage thérapeutique), Mâle, Peau (anatomopathologie), Photodermatoses (anatomopathologie), Photodermatoses (traitement médicamenteux), Sarcome de Kaposi (), Sarcome de Kaposi (anatomopathologie), Sujet âgé, Transformation cellulaire néoplasique (), Transformation cellulaire néoplasique (anatomopathologie), Tumeurs cutanées (), Tumeurs cutanées (anatomopathologie).
- MESH :
- anatomopathologie : Peau, Photodermatoses, Sarcome de Kaposi, Transformation cellulaire néoplasique, Tumeurs cutanées.
- effets indésirables : Ciclosporine, Immunosuppresseurs.
- traitement médicamenteux : Photodermatoses.
- usage thérapeutique : Ciclosporine, Immunosuppresseurs.
- Facteurs de risque, Humains, Mâle, Sarcome de Kaposi, Sujet âgé, Transformation cellulaire néoplasique, Tumeurs cutanées.
English descriptors
- KwdEn :
- Aged, Cell Transformation, Neoplastic (chemically induced), Cell Transformation, Neoplastic (pathology), Cyclosporine (adverse effects), Cyclosporine (therapeutic use), Humans, Immunosuppressive Agents (adverse effects), Immunosuppressive Agents (therapeutic use), Male, Photosensitivity Disorders (drug therapy), Photosensitivity Disorders (pathology), Risk Factors, Sarcoma, Kaposi (chemically induced), Sarcoma, Kaposi (pathology), Skin (pathology), Skin Neoplasms (chemically induced), Skin Neoplasms (pathology).
- MESH :
- chemical , adverse effects : Cyclosporine, Immunosuppressive Agents.
- chemically induced : Cell Transformation, Neoplastic, Sarcoma, Kaposi, Skin Neoplasms.
- drug therapy : Photosensitivity Disorders.
- pathology : Cell Transformation, Neoplastic, Photosensitivity Disorders, Sarcoma, Kaposi, Skin, Skin Neoplasms.
- chemical , therapeutic use : Cyclosporine, Immunosuppressive Agents.
- Aged, Humans, Male, Risk Factors.
Abstract
A 76 year old patient with actinic reticuloid was treated with Cyclosporin A. 11 months after beginning the immunosuppressive therapy, he developed lymphoedema and livid nodular skin lesions of the right leg, which histologically showed Kaposi's sarcoma. After stopping the Cyclosporin A and intralesional therapy with Interferon alpha, no regression of the Kaposi sarcoma could be seen. The characteristics of Kaposi sarcoma arising during immunosuppressive therapy and the differences in incidence, risk groups and distribution pattern compared to the classic sporadic and the AIDS-related Kaposi sarcoma will be described. The development of Kaposi sarcoma during immunosuppressive therapy for actinic reticuloid has not been previously described.
PubMed: 9206716
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 005017
- to stream PubMed, to step Curation: 005017
- to stream PubMed, to step Checkpoint: 005017
- to stream Ncbi, to step Merge: 00BA17
- to stream Ncbi, to step Curation: 00BA17
- to stream Ncbi, to step Checkpoint: 00BA17
- to stream Main, to step Merge: 00BE48
- to stream Main, to step Curation: 00B717
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid].</title><author><name sortKey="Waldmann, V" sort="Waldmann, V" uniqKey="Waldmann V" first="V" last="Waldmann">V. Waldmann</name><affiliation><nlm:affiliation>Dermatologische Klinik, Universitätsspital Zürich.</nlm:affiliation><wicri:noCountry code="subField">Universitätsspital Zürich</wicri:noCountry></affiliation></author><author><name sortKey="Kempf, W" sort="Kempf, W" uniqKey="Kempf W" first="W" last="Kempf">W. Kempf</name></author><author><name sortKey="Burg, G" sort="Burg, G" uniqKey="Burg G" first="G" last="Burg">G. Burg</name></author><author><name sortKey="Dummer, R" sort="Dummer, R" uniqKey="Dummer R" first="R" last="Dummer">R. Dummer</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1997">1997</date><idno type="RBID">pubmed:9206716</idno><idno type="pmid">9206716</idno><idno type="wicri:Area/PubMed/Corpus">005017</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005017</idno><idno type="wicri:Area/PubMed/Curation">005017</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005017</idno><idno type="wicri:Area/PubMed/Checkpoint">005017</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005017</idno><idno type="wicri:Area/Ncbi/Merge">00BA17</idno><idno type="wicri:Area/Ncbi/Curation">00BA17</idno><idno type="wicri:Area/Ncbi/Checkpoint">00BA17</idno><idno type="wicri:doubleKey">0017-8470:1997:Waldmann V:kaposi:sarcoma:in</idno><idno type="wicri:Area/Main/Merge">00BE48</idno><idno type="wicri:Area/Main/Curation">00B717</idno><idno type="wicri:Area/Main/Exploration">00B717</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid].</title><author><name sortKey="Waldmann, V" sort="Waldmann, V" uniqKey="Waldmann V" first="V" last="Waldmann">V. Waldmann</name><affiliation><nlm:affiliation>Dermatologische Klinik, Universitätsspital Zürich.</nlm:affiliation><wicri:noCountry code="subField">Universitätsspital Zürich</wicri:noCountry></affiliation></author><author><name sortKey="Kempf, W" sort="Kempf, W" uniqKey="Kempf W" first="W" last="Kempf">W. Kempf</name></author><author><name sortKey="Burg, G" sort="Burg, G" uniqKey="Burg G" first="G" last="Burg">G. Burg</name></author><author><name sortKey="Dummer, R" sort="Dummer, R" uniqKey="Dummer R" first="R" last="Dummer">R. Dummer</name></author></analytic><series><title level="j">Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete</title><idno type="ISSN">0017-8470</idno><imprint><date when="1997" type="published">1997</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Cell Transformation, Neoplastic (chemically induced)</term><term>Cell Transformation, Neoplastic (pathology)</term><term>Cyclosporine (adverse effects)</term><term>Cyclosporine (therapeutic use)</term><term>Humans</term><term>Immunosuppressive Agents (adverse effects)</term><term>Immunosuppressive Agents (therapeutic use)</term><term>Male</term><term>Photosensitivity Disorders (drug therapy)</term><term>Photosensitivity Disorders (pathology)</term><term>Risk Factors</term><term>Sarcoma, Kaposi (chemically induced)</term><term>Sarcoma, Kaposi (pathology)</term><term>Skin (pathology)</term><term>Skin Neoplasms (chemically induced)</term><term>Skin Neoplasms (pathology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Ciclosporine (effets indésirables)</term><term>Ciclosporine (usage thérapeutique)</term><term>Facteurs de risque</term><term>Humains</term><term>Immunosuppresseurs (effets indésirables)</term><term>Immunosuppresseurs (usage thérapeutique)</term><term>Mâle</term><term>Peau (anatomopathologie)</term><term>Photodermatoses (anatomopathologie)</term><term>Photodermatoses (traitement médicamenteux)</term><term>Sarcome de Kaposi ()</term><term>Sarcome de Kaposi (anatomopathologie)</term><term>Sujet âgé</term><term>Transformation cellulaire néoplasique ()</term><term>Transformation cellulaire néoplasique (anatomopathologie)</term><term>Tumeurs cutanées ()</term><term>Tumeurs cutanées (anatomopathologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Cyclosporine</term><term>Immunosuppressive Agents</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Peau</term><term>Photodermatoses</term><term>Sarcome de Kaposi</term><term>Transformation cellulaire néoplasique</term><term>Tumeurs cutanées</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Cell Transformation, Neoplastic</term><term>Sarcoma, Kaposi</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Photosensitivity Disorders</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Ciclosporine</term><term>Immunosuppresseurs</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Cell Transformation, Neoplastic</term><term>Photosensitivity Disorders</term><term>Sarcoma, Kaposi</term><term>Skin</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Cyclosporine</term><term>Immunosuppressive Agents</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Photodermatoses</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Ciclosporine</term><term>Immunosuppresseurs</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Humans</term><term>Male</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Facteurs de risque</term><term>Humains</term><term>Mâle</term><term>Sarcome de Kaposi</term><term>Sujet âgé</term><term>Transformation cellulaire néoplasique</term><term>Tumeurs cutanées</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A 76 year old patient with actinic reticuloid was treated with Cyclosporin A. 11 months after beginning the immunosuppressive therapy, he developed lymphoedema and livid nodular skin lesions of the right leg, which histologically showed Kaposi's sarcoma. After stopping the Cyclosporin A and intralesional therapy with Interferon alpha, no regression of the Kaposi sarcoma could be seen. The characteristics of Kaposi sarcoma arising during immunosuppressive therapy and the differences in incidence, risk groups and distribution pattern compared to the classic sporadic and the AIDS-related Kaposi sarcoma will be described. The development of Kaposi sarcoma during immunosuppressive therapy for actinic reticuloid has not been previously described.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Burg, G" sort="Burg, G" uniqKey="Burg G" first="G" last="Burg">G. Burg</name><name sortKey="Dummer, R" sort="Dummer, R" uniqKey="Dummer R" first="R" last="Dummer">R. Dummer</name><name sortKey="Kempf, W" sort="Kempf, W" uniqKey="Kempf W" first="W" last="Kempf">W. Kempf</name><name sortKey="Waldmann, V" sort="Waldmann, V" uniqKey="Waldmann V" first="V" last="Waldmann">V. Waldmann</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00B717 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00B717 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:9206716
|texte= [Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:9206716" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |